chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.42
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5
Symptoms: Intussusception
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 5 month old female who was vaccinated with Rotateq PO. There was no concomitant medication. The Nurse Practitioner reported that an infant received her second dose of Rotateq. In approximately April 007, "two to three weeks" later she developed intussusception and was hospitalized. The onset of the event was also reported as about one month ago. The child had surgery and is now fully recovered. The vaccine lot number was not provided by the reporter. The nurse practitioner reported that the intussusception required intervention to prevent serious criteria and caused or prolonged hospitalization. Additional information has been requested.
Age: 0.42
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5
Symptoms: Diarrhoea haemorrhagic, Intussusception, Surgery, Ultrasound abdomen, Vomiting
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 5 month old female who was vaccinated with Rotateq PO. There was no concomitant medication. The Nurse Practitioner reported that an infant received her second dose of Rotateq. In approximately April 007, "two to three weeks" later she developed intussusception and was hospitalized. The onset of the event was also reported as about one month ago. The child had surgery and is now fully recovered. The vaccine lot number was not provided by the reporter. The nurse practitioner reported that the intussusception required intervention to prevent serious criteria and caused or prolonged hospitalization. Additional information has been requested.
Age: 0.42
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5, DTAPHEPBIP, HIBV, PNC, RV5, RV5
Symptoms: Intussusception, Surgery
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 5 month old female who was vaccinated with Rotateq PO. There was no concomitant medication. The Nurse Practitioner reported that an infant received her second dose of Rotateq. In approximately April 007, "two to three weeks" later she developed intussusception and was hospitalized. The onset of the event was also reported as about one month ago. The child had surgery and is now fully recovered. The vaccine lot number was not provided by the reporter. The nurse practitioner reported that the intussusception required intervention to prevent serious criteria and caused or prolonged hospitalization. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, HPV4, DTAP, HEPA, HPV4, MNQ
Symptoms: Gaze palsy, Loss of consciousness, Muscle rigidity, Pallor, Staring
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA03302. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow-up information has been received from a physician and a health care professional concerning a 18 year female patient with no known seizure disorder, allergic rhinitis, exercise induced asthma and a history of passing out while giving blood who on 03-APR-2007 was vaccinated IM in right deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included HAVRIX, MENACTRA and Dtap. The physician reported that the patient convulsed almost immediately after receiving the Gardasil, but he did not witness the patient's experience. He stated that approximately 5 minutes after receiving the injection the patient became very stiff, rigid, eyes rolled back and passed out for approximately 30 seconds. He reported that this patient was "really out of it." Vital signs before and after the seizure were normal. The physician's office followed up with the patient next day and the patient was doing fine. The physician did not consider the event to be serious." "In follow-up report a health care professional reported that when the patient came to she had postictal signs and symptoms of a "blank stare" for about 5-10 second. She became awake, alert and orient to time, place and people (AAOx3). Blood pressure was 116/78, pulse was 64 and pulse oximetry was 97%. Before vaccine was administered the blood pressure measurement was 115/65. On 03-APR-2007 patient recovered. The physician did not consider the event to be serious. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil. Additional information is not expected." The reporter in this case is the same as in case 2007-01539.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, HPV4, DTAP, HEPA, HPV4, MNQ
Symptoms: Condition aggravated, Convulsion
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA03302. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow-up information has been received from a physician and a health care professional concerning a 18 year female patient with no known seizure disorder, allergic rhinitis, exercise induced asthma and a history of passing out while giving blood who on 03-APR-2007 was vaccinated IM in right deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included HAVRIX, MENACTRA and Dtap. The physician reported that the patient convulsed almost immediately after receiving the Gardasil, but he did not witness the patient's experience. He stated that approximately 5 minutes after receiving the injection the patient became very stiff, rigid, eyes rolled back and passed out for approximately 30 seconds. He reported that this patient was "really out of it." Vital signs before and after the seizure were normal. The physician's office followed up with the patient next day and the patient was doing fine. The physician did not consider the event to be serious." "In follow-up report a health care professional reported that when the patient came to she had postictal signs and symptoms of a "blank stare" for about 5-10 second. She became awake, alert and orient to time, place and people (AAOx3). Blood pressure was 116/78, pulse was 64 and pulse oximetry was 97%. Before vaccine was administered the blood pressure measurement was 115/65. On 03-APR-2007 patient recovered. The physician did not consider the event to be serious. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil. Additional information is not expected." The reporter in this case is the same as in case 2007-01539.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, HPV4, DTAP, HEPA, HPV4, MNQ
Symptoms: Blood pressure normal, Convulsion, Eye rolling, Heart rate normal, Immediate post-injection reaction
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA03302. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow-up information has been received from a physician and a health care professional concerning a 18 year female patient with no known seizure disorder, allergic rhinitis, exercise induced asthma and a history of passing out while giving blood who on 03-APR-2007 was vaccinated IM in right deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included HAVRIX, MENACTRA and Dtap. The physician reported that the patient convulsed almost immediately after receiving the Gardasil, but he did not witness the patient's experience. He stated that approximately 5 minutes after receiving the injection the patient became very stiff, rigid, eyes rolled back and passed out for approximately 30 seconds. He reported that this patient was "really out of it." Vital signs before and after the seizure were normal. The physician's office followed up with the patient next day and the patient was doing fine. The physician did not consider the event to be serious." "In follow-up report a health care professional reported that when the patient came to she had postictal signs and symptoms of a "blank stare" for about 5-10 second. She became awake, alert and orient to time, place and people (AAOx3). Blood pressure was 116/78, pulse was 64 and pulse oximetry was 97%. Before vaccine was administered the blood pressure measurement was 115/65. On 03-APR-2007 patient recovered. The physician did not consider the event to be serious. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil. Additional information is not expected." The reporter in this case is the same as in case 2007-01539.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, HPV4, DTAP, HEPA, HPV4, MNQ
Symptoms: Inappropriate schedule of drug administration, Loss of consciousness, Medication error, Muscle rigidity, Musculoskeletal stiffness
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA03302. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow-up information has been received from a physician and a health care professional concerning a 18 year female patient with no known seizure disorder, allergic rhinitis, exercise induced asthma and a history of passing out while giving blood who on 03-APR-2007 was vaccinated IM in right deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included HAVRIX, MENACTRA and Dtap. The physician reported that the patient convulsed almost immediately after receiving the Gardasil, but he did not witness the patient's experience. He stated that approximately 5 minutes after receiving the injection the patient became very stiff, rigid, eyes rolled back and passed out for approximately 30 seconds. He reported that this patient was "really out of it." Vital signs before and after the seizure were normal. The physician's office followed up with the patient next day and the patient was doing fine. The physician did not consider the event to be serious." "In follow-up report a health care professional reported that when the patient came to she had postictal signs and symptoms of a "blank stare" for about 5-10 second. She became awake, alert and orient to time, place and people (AAOx3). Blood pressure was 116/78, pulse was 64 and pulse oximetry was 97%. Before vaccine was administered the blood pressure measurement was 115/65. On 03-APR-2007 patient recovered. The physician did not consider the event to be serious. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil. Additional information is not expected." The reporter in this case is the same as in case 2007-01539.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, HPV4, DTAP, HEPA, HPV4, MNQ
Symptoms: Oxygen saturation, Oxygen saturation normal, Postictal state, Staring
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA03302. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow-up information has been received from a physician and a health care professional concerning a 18 year female patient with no known seizure disorder, allergic rhinitis, exercise induced asthma and a history of passing out while giving blood who on 03-APR-2007 was vaccinated IM in right deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included HAVRIX, MENACTRA and Dtap. The physician reported that the patient convulsed almost immediately after receiving the Gardasil, but he did not witness the patient's experience. He stated that approximately 5 minutes after receiving the injection the patient became very stiff, rigid, eyes rolled back and passed out for approximately 30 seconds. He reported that this patient was "really out of it." Vital signs before and after the seizure were normal. The physician's office followed up with the patient next day and the patient was doing fine. The physician did not consider the event to be serious." "In follow-up report a health care professional reported that when the patient came to she had postictal signs and symptoms of a "blank stare" for about 5-10 second. She became awake, alert and orient to time, place and people (AAOx3). Blood pressure was 116/78, pulse was 64 and pulse oximetry was 97%. Before vaccine was administered the blood pressure measurement was 115/65. On 03-APR-2007 patient recovered. The physician did not consider the event to be serious. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil. Additional information is not expected." The reporter in this case is the same as in case 2007-01539.
Age: 0.5
Sex: M
Vaccine: DTAP, HBHEPB, PPV, RV5, DTAP, HBHEPB, PNC, RV5
Symptoms: Intussusception, Wrong drug administered
Clinical narrative: Initial report received on 04 May 2007 from another manufacturer, report # WAES0704USA02415. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 6 month old male with no medical history who on 01-MAR-2007 was vaccinated with a 2 mL PO third dose of Rotateq (Lot# 656185/1243F). Concomitant vaccination administered the same day included a third IM dose of PREVNAR (lot# B47742A), A third IM dose of of COMVAX (lot# 655548/1243F) and a third IM dose of TRIPEDIA (lot# U1751BA). There was no illness at the time of vaccination. On 19-MAR-2007 the patient developed intussusception and was hospitalized. It was reported that the patient had bloody stool and underwent an ultrasound on 20-MAR-2007. The ultrasound findings indicated that the patient had ileocolic intussusception extending to the level of the hepatic flexture and a small amount of free fluid was identified in the sub hepatic space. The patient underwent a barium enema. Surgery was not required. An abdominal ultrasound on 21-MAR-2007 indicated that there was no evidence for recurrent intussusception. It was reported that on 21-MAR-2007 at 7 am the patient had vomiting that lasted 2 days and dark bowel movements that lasted one day. Subsequently, the patient recovered from intussusception on 22-MAR-2007. Neither the patient nor his sibling experienced an adverse event following prior vaccination. There was no product quality complaint involved. A lot check was requested. The records of testing prior to release of the lot in question has been rechecked and found to be satisfactory. The lot met the requirements of the agency and was released. Additional information is not expected.
Age: 0.5
Sex: M
Vaccine: DTAP, HBHEPB, PPV, RV5, DTAP, HBHEPB, PNC, RV5
Symptoms: Barium enema, Faeces discoloured, Haematochezia, Intussusception, Ultrasound abdomen
Clinical narrative: Initial report received on 04 May 2007 from another manufacturer, report # WAES0704USA02415. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 6 month old male with no medical history who on 01-MAR-2007 was vaccinated with a 2 mL PO third dose of Rotateq (Lot# 656185/1243F). Concomitant vaccination administered the same day included a third IM dose of PREVNAR (lot# B47742A), A third IM dose of of COMVAX (lot# 655548/1243F) and a third IM dose of TRIPEDIA (lot# U1751BA). There was no illness at the time of vaccination. On 19-MAR-2007 the patient developed intussusception and was hospitalized. It was reported that the patient had bloody stool and underwent an ultrasound on 20-MAR-2007. The ultrasound findings indicated that the patient had ileocolic intussusception extending to the level of the hepatic flexture and a small amount of free fluid was identified in the sub hepatic space. The patient underwent a barium enema. Surgery was not required. An abdominal ultrasound on 21-MAR-2007 indicated that there was no evidence for recurrent intussusception. It was reported that on 21-MAR-2007 at 7 am the patient had vomiting that lasted 2 days and dark bowel movements that lasted one day. Subsequently, the patient recovered from intussusception on 22-MAR-2007. Neither the patient nor his sibling experienced an adverse event following prior vaccination. There was no product quality complaint involved. A lot check was requested. The records of testing prior to release of the lot in question has been rechecked and found to be satisfactory. The lot met the requirements of the agency and was released. Additional information is not expected.
Age: 0.5
Sex: M
Vaccine: DTAP, HBHEPB, PPV, RV5, DTAP, HBHEPB, PNC, RV5
Symptoms: Vomiting
Clinical narrative: Initial report received on 04 May 2007 from another manufacturer, report # WAES0704USA02415. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Information has been received from a physician concerning a 6 month old male with no medical history who on 01-MAR-2007 was vaccinated with a 2 mL PO third dose of Rotateq (Lot# 656185/1243F). Concomitant vaccination administered the same day included a third IM dose of PREVNAR (lot# B47742A), A third IM dose of of COMVAX (lot# 655548/1243F) and a third IM dose of TRIPEDIA (lot# U1751BA). There was no illness at the time of vaccination. On 19-MAR-2007 the patient developed intussusception and was hospitalized. It was reported that the patient had bloody stool and underwent an ultrasound on 20-MAR-2007. The ultrasound findings indicated that the patient had ileocolic intussusception extending to the level of the hepatic flexture and a small amount of free fluid was identified in the sub hepatic space. The patient underwent a barium enema. Surgery was not required. An abdominal ultrasound on 21-MAR-2007 indicated that there was no evidence for recurrent intussusception. It was reported that on 21-MAR-2007 at 7 am the patient had vomiting that lasted 2 days and dark bowel movements that lasted one day. Subsequently, the patient recovered from intussusception on 22-MAR-2007. Neither the patient nor his sibling experienced an adverse event following prior vaccination. There was no product quality complaint involved. A lot check was requested. The records of testing prior to release of the lot in question has been rechecked and found to be satisfactory. The lot met the requirements of the agency and was released. Additional information is not expected.
Age: 13.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, MNQ, VARCEL
Symptoms: Convulsion, Gaze palsy
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA02668. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow up information has been received from a physician concerning a 13 year old female patient who on 11-APR-2007, was vaccinated IM in left deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included Varivax, MENACTRA and HAVRIX. The patient's blood pressure (BP) prior to vaccination was 112/68 mmHg. The patient started to convulse in front of the physician and her eyes rolled back after receiving the Gardasil. Almost immediately the patient became very stiff, rigid, and passed out for approximately 30 seconds. The physician reported that the patient was "really out of it." BP after seizure was 102/78 and pulse oximetry was 98%. The patient recovered from the seizure but was experiencing headaches since the injection was given. The physician's office followed up with the patient the next day and she was doing fine. The physician did not consider the event to be serious." "In follow-up report from the physician's office it was reported that patient became pale for about one minute and when she came to she had postictal signs and symptoms of a blank stare for about five to ten seconds and no response. She did walk back to the room without much time. When she got back to the room she became "limp" and needed to be lifted. On 11-APR-2007 the patient recovered. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil vaccine. Additional information is not expected." The reporter in this case is the same as in case 2007-01540.
Age: 13.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, MNQ, VARCEL
Symptoms: Blood pressure decreased, Convulsion, Eye rolling, Headache, Hypotonia
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA02668. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow up information has been received from a physician concerning a 13 year old female patient who on 11-APR-2007, was vaccinated IM in left deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included Varivax, MENACTRA and HAVRIX. The patient's blood pressure (BP) prior to vaccination was 112/68 mmHg. The patient started to convulse in front of the physician and her eyes rolled back after receiving the Gardasil. Almost immediately the patient became very stiff, rigid, and passed out for approximately 30 seconds. The physician reported that the patient was "really out of it." BP after seizure was 102/78 and pulse oximetry was 98%. The patient recovered from the seizure but was experiencing headaches since the injection was given. The physician's office followed up with the patient the next day and she was doing fine. The physician did not consider the event to be serious." "In follow-up report from the physician's office it was reported that patient became pale for about one minute and when she came to she had postictal signs and symptoms of a blank stare for about five to ten seconds and no response. She did walk back to the room without much time. When she got back to the room she became "limp" and needed to be lifted. On 11-APR-2007 the patient recovered. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil vaccine. Additional information is not expected." The reporter in this case is the same as in case 2007-01540.
Age: 13.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, MNQ, VARCEL
Symptoms: Loss of consciousness, Muscle rigidity, Musculoskeletal stiffness, Oxygen saturation, Pallor
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA02668. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow up information has been received from a physician concerning a 13 year old female patient who on 11-APR-2007, was vaccinated IM in left deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included Varivax, MENACTRA and HAVRIX. The patient's blood pressure (BP) prior to vaccination was 112/68 mmHg. The patient started to convulse in front of the physician and her eyes rolled back after receiving the Gardasil. Almost immediately the patient became very stiff, rigid, and passed out for approximately 30 seconds. The physician reported that the patient was "really out of it." BP after seizure was 102/78 and pulse oximetry was 98%. The patient recovered from the seizure but was experiencing headaches since the injection was given. The physician's office followed up with the patient the next day and she was doing fine. The physician did not consider the event to be serious." "In follow-up report from the physician's office it was reported that patient became pale for about one minute and when she came to she had postictal signs and symptoms of a blank stare for about five to ten seconds and no response. She did walk back to the room without much time. When she got back to the room she became "limp" and needed to be lifted. On 11-APR-2007 the patient recovered. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil vaccine. Additional information is not expected." The reporter in this case is the same as in case 2007-01540.
Age: 13.0
Sex: F
Vaccine: HPV4, HEPA, HPV4, MNQ, VARCEL
Symptoms: Postictal state, Staring, Unresponsive to stimuli
Clinical narrative: SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 04 May 2007 from another manufacturer, report# WAES0704USA02668. The initial reporter to this manufacturer had been a health care professional. Verbatim from the report: "Initial and follow up information has been received from a physician concerning a 13 year old female patient who on 11-APR-2007, was vaccinated IM in left deltoid with a dose of Gardasil, lot #655849/0263U. Concomitant therapy included Varivax, MENACTRA and HAVRIX. The patient's blood pressure (BP) prior to vaccination was 112/68 mmHg. The patient started to convulse in front of the physician and her eyes rolled back after receiving the Gardasil. Almost immediately the patient became very stiff, rigid, and passed out for approximately 30 seconds. The physician reported that the patient was "really out of it." BP after seizure was 102/78 and pulse oximetry was 98%. The patient recovered from the seizure but was experiencing headaches since the injection was given. The physician's office followed up with the patient the next day and she was doing fine. The physician did not consider the event to be serious." "In follow-up report from the physician's office it was reported that patient became pale for about one minute and when she came to she had postictal signs and symptoms of a blank stare for about five to ten seconds and no response. She did walk back to the room without much time. When she got back to the room she became "limp" and needed to be lifted. On 11-APR-2007 the patient recovered. Upon internal review, convulsion was considered to be an other important medical event. The physician reported that another patient in the same age group convulsed after receiving the Gardasil vaccine. Additional information is not expected." The reporter in this case is the same as in case 2007-01540.
Age: 65.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Anoxic encephalopathy, Blood glucose increased, Carpal tunnel syndrome, Encephalitis, Endotracheal intubation
Clinical narrative: Patient was found unconscious, having seizures. He had been alone and was not found for approximately 24 hours. Diagnosis at  Medical Center was viral encephalitis. Patient's fever was 103.8, his breathing was shallow and his blood sugar was over 400. Since entering the hospital his
Age: 65.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Inguinal hernia, Monocyte count decreased, Neutrophil count increased
Clinical narrative: Patient was found unconscious, having seizures. He had been alone and was not found for approximately 24 hours. Diagnosis at  Medical Center was viral encephalitis. Patient's fever was 103.8, his breathing was shallow and his blood sugar was over 400. Since entering the hospital his
Age: 65.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blood glucose increased, Blood test, Convulsion, Electroencephalogram, Encephalitis viral
Clinical narrative: Patient was found unconscious, having seizures. He had been alone and was not found for approximately 24 hours. Diagnosis at  Medical Center was viral encephalitis. Patient's fever was 103.8, his breathing was shallow and his blood sugar was over 400. Since entering the hospital his
Age: 65.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Hypoventilation, Loss of consciousness, Lumbar puncture, Nuclear magnetic resonance imaging, Pyrexia
Clinical narrative: Patient was found unconscious, having seizures. He had been alone and was not found for approximately 24 hours. Diagnosis at  Medical Center was viral encephalitis. Patient's fever was 103.8, his breathing was shallow and his blood sugar was over 400. Since entering the hospital his
Age: 24.0
Sex: F
Vaccine: HEP, HEPA, VARCEL, VARCEL
Symptoms: Blister, Headache, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 24 year old female with diabetes, shell fish allergy and hypersensitivity to ceftazadime and linezolid. The patient, who was not immunocompromised or on any immunosuppressive medication, has severe cystic fibrosis and was not a "normal, healthy individual". The patient was on "around twenty different medications", of which the details were not provided. On 13-APR-2007 the patient was vaccinated subcutaneously with one dose, 0.5ml, varicella virus vaccine live. Subsequently the patient developed an injection site rash that disseminated into a varicella-like rash on her face and trunk. There were approximately 14 lesions. The reporting physician indicated that the patient was in the process of preparing for a lung transplant. The patient developed decreased pulmonary status and was hospitalized as a precautionary measure due to her pulmonary status. The patient's oxygen saturation on room air was 93%, which is lower that her usual baseline. The patient did not have pneumonitis or pneumonia. Unspecified pulmonary function testing was performed, of which the results were not reported. The physician, who was informed about the Varicella Zoster Identification Program (VZIP), indicated that she was uncertain if she would submit any lesion or sputum specimens. At the time of reporting the status of the patients lesions were unknown. The patient was currently being treated with acyclovir. There was no product quality complaint.
Age: 24.0
Sex: F
Vaccine: HEP, HEPA, VARCEL, VARCEL
Symptoms: Injection site rash, Lung disorder, Oxygen saturation, Oxygen saturation decreased, Pulmonary function test
Clinical narrative: Information has been received from a physician concerning a 24 year old female with diabetes, shell fish allergy and hypersensitivity to ceftazadime and linezolid. The patient, who was not immunocompromised or on any immunosuppressive medication, has severe cystic fibrosis and was not a "normal, healthy individual". The patient was on "around twenty different medications", of which the details were not provided. On 13-APR-2007 the patient was vaccinated subcutaneously with one dose, 0.5ml, varicella virus vaccine live. Subsequently the patient developed an injection site rash that disseminated into a varicella-like rash on her face and trunk. There were approximately 14 lesions. The reporting physician indicated that the patient was in the process of preparing for a lung transplant. The patient developed decreased pulmonary status and was hospitalized as a precautionary measure due to her pulmonary status. The patient's oxygen saturation on room air was 93%, which is lower that her usual baseline. The patient did not have pneumonitis or pneumonia. Unspecified pulmonary function testing was performed, of which the results were not reported. The physician, who was informed about the Varicella Zoster Identification Program (VZIP), indicated that she was uncertain if she would submit any lesion or sputum specimens. At the time of reporting the status of the patients lesions were unknown. The patient was currently being treated with acyclovir. There was no product quality complaint.
Age: 24.0
Sex: F
Vaccine: HEP, HEPA, VARCEL, VARCEL
Symptoms: Rash vesicular, Skin lesion
Clinical narrative: Information has been received from a physician concerning a 24 year old female with diabetes, shell fish allergy and hypersensitivity to ceftazadime and linezolid. The patient, who was not immunocompromised or on any immunosuppressive medication, has severe cystic fibrosis and was not a "normal, healthy individual". The patient was on "around twenty different medications", of which the details were not provided. On 13-APR-2007 the patient was vaccinated subcutaneously with one dose, 0.5ml, varicella virus vaccine live. Subsequently the patient developed an injection site rash that disseminated into a varicella-like rash on her face and trunk. There were approximately 14 lesions. The reporting physician indicated that the patient was in the process of preparing for a lung transplant. The patient developed decreased pulmonary status and was hospitalized as a precautionary measure due to her pulmonary status. The patient's oxygen saturation on room air was 93%, which is lower that her usual baseline. The patient did not have pneumonitis or pneumonia. Unspecified pulmonary function testing was performed, of which the results were not reported. The physician, who was informed about the Varicella Zoster Identification Program (VZIP), indicated that she was uncertain if she would submit any lesion or sputum specimens. At the time of reporting the status of the patients lesions were unknown. The patient was currently being treated with acyclovir. There was no product quality complaint.
Age: 54.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Depression, Dysphonia, Fatigue, Flushing, Headache
Clinical narrative: Pt had HA PM of injection 4/26/07 and felt sick. On 4/27/07 developed hives and itching. Took Benadryl. On 4/28/07 seen in clinic - Hives and itch, but improving. 4/29/07 stopped Benadryl. 4/30/07 hives and itch back - will restart Benadryl
Age: 54.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Injection site pain, Irritability, Malaise, Nausea, Pruritus
Clinical narrative: Pt had HA PM of injection 4/26/07 and felt sick. On 4/27/07 developed hives and itching. Took Benadryl. On 4/28/07 seen in clinic - Hives and itch, but improving. 4/29/07 stopped Benadryl. 4/30/07 hives and itch back - will restart Benadryl
Age: 54.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Urticaria
Clinical narrative: Pt had HA PM of injection 4/26/07 and felt sick. On 4/27/07 developed hives and itching. Took Benadryl. On 4/28/07 seen in clinic - Hives and itch, but improving. 4/29/07 stopped Benadryl. 4/30/07 hives and itch back - will restart Benadryl
Age: 54.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Headache, Malaise, Pruritus, Urticaria
Clinical narrative: Pt had HA PM of injection 4/26/07 and felt sick. On 4/27/07 developed hives and itching. Took Benadryl. On 4/28/07 seen in clinic - Hives and itch, but improving. 4/29/07 stopped Benadryl. 4/30/07 hives and itch back - will restart Benadryl
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Biopsy brain, Bone pain, Computerised tomogram, Convulsion
Clinical narrative: Seizures, right sided brain lesion, memory lapses, fatigue, bone-joint pain, started September 28, 2000, 2 stereotactic-guided brain biopsies, MRI, CAT scans, EEGs, no answer to anything. Many hospitalizations.  6/26/07 Received 2nd hosp med recs which reveal patient experienced new onset gen tonic-clonic seizure on 9/29/00 followed by repeated partial seizures 11/25/00.  Admitted 11/25-11/28/00.  Right frontal mass had been biopsied in 9/00 at 1st hospital revealed reactive gliosis w/increased benign appearing oligodendroglia cells.  Cytology was neg.  After biopsy, patient had paresis of LUE & face which resolved w/steroids but returned in 10/00 & tx w/steroids again.  Had been seizure free on Dilantin prior to the 11/00 admit.  Repeat CT scan revealed known lesions w/significant vasogenic edema & 5 mm midline shift, felt to be malignant.  Meds adjusted & additional anti seizure med added. No further seizure activity noted for this admission. FINAL DX: Focal motor seizures & right frontal mass.  7/20/07 Received medical records from NMC which reveal patient initially admitted 9/29-10/6/00 for Seizure disorder & right frontal cystic brain lesion.  Craniotomy for evacuation of the cyst & brain biopsy done at that time.  Prior to admit patient had 3 days of focal seizures which progressed to generalized seizure on day of admit.  Loaded w/anticonvulsant & steroids meds.  Progressed well & d/c to home on multiple meds. Returned to ERat outlying hospital over holidays(see above notes) Admitted to NMC  11/30-12/3/00 for status epilepticus.   Craniotomy & biopsy was repeated & revealed gliosis.  Had mild left facial weakness post op.  D/C to home on continued steroids & anticonvulsants. 12/14/00 Evaluated by oncology for unresectable low-grade astrocytoma of right frontal lobe.  Felt to be good canididate for rad & chemo tx; however, patient was reluctant to receive chemo tx. 1/5/01 Had appendectomy w/o complication. 2/5-2/8/01 Readmitted to hospital due to neurocystosarcoma & suspected neurocysticercpsos fpr ID drug treatment.  Responded well.  No seizure activity noted during admission.  D/C to home to f/u w/ID & neurosurgery.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Electroencephalogram, Fatigue, Laboratory test, Memory impairment, Nervous system disorder
Clinical narrative: Seizures, right sided brain lesion, memory lapses, fatigue, bone-joint pain, started September 28, 2000, 2 stereotactic-guided brain biopsies, MRI, CAT scans, EEGs, no answer to anything. Many hospitalizations.  6/26/07 Received 2nd hosp med recs which reveal patient experienced new onset gen tonic-clonic seizure on 9/29/00 followed by repeated partial seizures 11/25/00.  Admitted 11/25-11/28/00.  Right frontal mass had been biopsied in 9/00 at 1st hospital revealed reactive gliosis w/increased benign appearing oligodendroglia cells.  Cytology was neg.  After biopsy, patient had paresis of LUE & face which resolved w/steroids but returned in 10/00 & tx w/steroids again.  Had been seizure free on Dilantin prior to the 11/00 admit.  Repeat CT scan revealed known lesions w/significant vasogenic edema & 5 mm midline shift, felt to be malignant.  Meds adjusted & additional anti seizure med added. No further seizure activity noted for this admission. FINAL DX: Focal motor seizures & right frontal mass.  7/20/07 Received medical records from NMC which reveal patient initially admitted 9/29-10/6/00 for Seizure disorder & right frontal cystic brain lesion.  Craniotomy for evacuation of the cyst & brain biopsy done at that time.  Prior to admit patient had 3 days of focal seizures which progressed to generalized seizure on day of admit.  Loaded w/anticonvulsant & steroids meds.  Progressed well & d/c to home on multiple meds. Returned to ERat outlying hospital over holidays(see above notes) Admitted to NMC  11/30-12/3/00 for status epilepticus.   Craniotomy & biopsy was repeated & revealed gliosis.  Had mild left facial weakness post op.  D/C to home on continued steroids & anticonvulsants. 12/14/00 Evaluated by oncology for unresectable low-grade astrocytoma of right frontal lobe.  Felt to be good canididate for rad & chemo tx; however, patient was reluctant to receive chemo tx. 1/5/01 Had appendectomy w/o complication. 2/5-2/8/01 Readmitted to hospital due to neurocystosarcoma & suspected neurocysticercpsos fpr ID drug treatment.  Responded well.  No seizure activity noted during admission.  D/C to home to f/u w/ID & neurosurgery.
Age: 21.0
Sex: M
Vaccine: ANTH
Symptoms: Nuclear magnetic resonance imaging
Clinical narrative: Seizures, right sided brain lesion, memory lapses, fatigue, bone-joint pain, started September 28, 2000, 2 stereotactic-guided brain biopsies, MRI, CAT scans, EEGs, no answer to anything. Many hospitalizations.  6/26/07 Received 2nd hosp med recs which reveal patient experienced new onset gen tonic-clonic seizure on 9/29/00 followed by repeated partial seizures 11/25/00.  Admitted 11/25-11/28/00.  Right frontal mass had been biopsied in 9/00 at 1st hospital revealed reactive gliosis w/increased benign appearing oligodendroglia cells.  Cytology was neg.  After biopsy, patient had paresis of LUE & face which resolved w/steroids but returned in 10/00 & tx w/steroids again.  Had been seizure free on Dilantin prior to the 11/00 admit.  Repeat CT scan revealed known lesions w/significant vasogenic edema & 5 mm midline shift, felt to be malignant.  Meds adjusted & additional anti seizure med added. No further seizure activity noted for this admission. FINAL DX: Focal motor seizures & right frontal mass.  7/20/07 Received medical records from NMC which reveal patient initially admitted 9/29-10/6/00 for Seizure disorder & right frontal cystic brain lesion.  Craniotomy for evacuation of the cyst & brain biopsy done at that time.  Prior to admit patient had 3 days of focal seizures which progressed to generalized seizure on day of admit.  Loaded w/anticonvulsant & steroids meds.  Progressed well & d/c to home on multiple meds. Returned to ERat outlying hospital over holidays(see above notes) Admitted to NMC  11/30-12/3/00 for status epilepticus.   Craniotomy & biopsy was repeated & revealed gliosis.  Had mild left facial weakness post op.  D/C to home on continued steroids & anticonvulsants. 12/14/00 Evaluated by oncology for unresectable low-grade astrocytoma of right frontal lobe.  Felt to be good canididate for rad & chemo tx; however, patient was reluctant to receive chemo tx. 1/5/01 Had appendectomy w/o complication. 2/5-2/8/01 Readmitted to hospital due to neurocystosarcoma & suspected neurocysticercpsos fpr ID drug treatment.  Responded well.  No seizure activity noted during admission.  D/C to home to f/u w/ID & neurosurgery.
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site nodule
Clinical narrative: redness, slight induration, with knot under skin at the injection site
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Axillary mass, Axillary pain, Injection site pain, Oedema peripheral, Pain in extremity
Clinical narrative: HE WOKE UP THE FOLLOWING DAY AFTER VACCINATION IM WITH PAIN LOCALIZED ON LOWER 1/3 OF LEFT AXILLA , SAME SIDE OF DELTOID MUCLE . AREA IS SWOLLEN , NO MASS IS PALPATED. OVERLYING SKIN IS NORMAL.AREA OF VACCINATION IS NORMAL WITH MINIMAL TENDERNESS.NO FEVER.PATIENT IS TAKING ADVIL 400 MG PO BID
Age: 14.0
Sex: M
Vaccine: IPV, TDAP, VARCEL
Symptoms: Dyskinesia, Hyperhidrosis, Hypotonia, Hypoventilation, Pallor
Clinical narrative: Hispanic male recieved Tdap, IPV, and Varicella vaccines in left arm.  Almost immediately, patient became limp, gray in color, sweaty, then exhibited seizure like jerks in arms and legs.  Loss of bladder control followed. Initial vital signs BP 90/50, pulse 78 thready and weak, resp 12 and shallow. Patient unresponsive to voice commands. 911 called. 8 minutes later vital signs BP 100/52, pulse 80, resp 18 and normal. Paramedics arrive, patient transported to ER.
Age: 14.0
Sex: M
Vaccine: IPV, TDAP, VARCEL
Symptoms: Pulse pressure decreased, Unresponsive to stimuli, Urinary incontinence
Clinical narrative: Hispanic male recieved Tdap, IPV, and Varicella vaccines in left arm.  Almost immediately, patient became limp, gray in color, sweaty, then exhibited seizure like jerks in arms and legs.  Loss of bladder control followed. Initial vital signs BP 90/50, pulse 78 thready and weak, resp 12 and shallow. Patient unresponsive to voice commands. 911 called. 8 minutes later vital signs BP 100/52, pulse 80, resp 18 and normal. Paramedics arrive, patient transported to ER.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Full blood count, Haematochezia
Clinical narrative: hematochezia on day 3 after vaccine - suspect Rotateq was the cause. with scant intermittent blood in stools
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: L THIGH REACTION 2.5/4 CM ERTHEMATOUS, MILD EDEMATOUS AREA 0.5 CM AWAY FROM ACTUAL NEEDLE MARK.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Eye swelling, Lip swelling, Pruritus, Urticaria
Clinical narrative: Onset of hives, itching, swollen lips and eyes 45 minutes after immunes given.  Child taken immediately to hospital ER.
Age: 21.0
Sex: M
Vaccine: SMALL, TYP
Symptoms: Myocarditis
Clinical narrative: Patient admitted to hospital over the weekend of 11-13 May 2007 with myocarditis. 05/22/2007 MR received for a 4 night admission (5/8-12/2007) for c/o chest pain x 2 days which was worsening. He had previously had a significant reaction to small pox vaccine evidenced by swelling and discomfort under his arm and swelling of the cervical and supraclavicular lymph nodes.  Chest pain was most significant with lying down and deep breathing, somewhat relieved by standing.  Upon exam in the ER pt. was febrile with redness and swelling at the small pox vax site on the L arm.  Otherwise PE WNL. ID consult 5/8/07 with DX:  Viral vs post-vaccination myopericarditis. Pt. experienced an episode of desaturation on 5/9/07, but improvement was noted and pt was d/c on 5/12/07.   Discharge DX: Viral myopericarditis.
Age: 16.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Local swelling, Pharyngeal oedema, Tonsillitis
Clinical narrative: Patient awoke in the middle of the night with a swollen throat, but had no difficulty breathing.  Her father, who is a physician, said that her tonsils and uvula looked swollen.  Mom felt her neck looked swollen.  She had not had any other exposures such as to insects.  The child went to school the next day and did not worsen.  Mom went to the school and gave otc benadryl 50mg to the child, which caused the symptoms to resolve completely in 20 minutes .  The child was never seen in our office for the reaction.  All information was supplied to us by the mother of the patient.  The child has no residual problems.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: RIGHT DELTOID AREA WARM ERYTHEMA >3CM DIAMETER, NOT SPECIFICALLY TENDER TO PALPATION
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Rash pruritic
Clinical narrative: Fine red, raised, pruritic rash noted over both arms two days after vaccine was given. No fever. No other complaints. Fading as of day five after vaccine given. Treated by school nurse with Benadryl 25mg p.o. Pt. repeated Bendaryl over next two days.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash generalised
Clinical narrative: ON 5-3 PT RECEIVED MMR AND VARICELLA VACCINE, ON 5-12 PT DEVELOPED RASH ALL OVER BODY AS WELL AS FEVER OF 102+.
Age: 11.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Nuclear magnetic resonance imaging, Osteomyelitis
Clinical narrative: Severe redness, tenderness at the sight of the injection; diagnosed with cellulitis and osteomyelitis in the upper right arm which coincides with the sight of the injections; symptoms appeared less than 36 hours after the immunization; admitted to the hospital through the emergency room for treatment of the above conditions; bone scan and MRI done to confirm diagnosis; IV antibiotics for six weeks through PICC line after discharge from hospital.  05/17/2007 MR received for a 3 night admit (4/27-30/07) for cellulitis and osteomyelitis of the Right shoulder where she had received Pneumovax. She developed fever, malaise, and generalized weakness the day following her vax. Fever increased the next day to 103.1'F and erythema and induration of the right shoulder developed with decreased ROM.   MRI revealed cellulitis and osteomyelitis of the right humerus so she was admitted for management. PE: WNL except severe erythema and induration of the R shoulder.  Tender to touch.  Decreased ROM.  Txd with IV abx and discharged with PICC line for home IV abx. Final DX:  Right Osteomyelitis and Cellulitis of the R proximal humerus.  SIRS 2' to Cellulitis.  Possibility of underlying immunodeficiency considering recurrent infections.